Cor Vasa 2009, 51(11-12):817-820 | DOI: 10.33678/cor.2009.196
Subacute stent thrombosis associated with high residual platelet activity
- 1 Kardiovaskulární centrum pro dospělé, Fakultní nemocnice v Motole a 1. lékařská fakulta Univerzity Karlovy
- 2 Ústav hematologie a krevní transfuze
- 3 Klinika zobrazovacích metod, Fakultní nemocnice v Motole a 2. lékařská fakulta Univerzity Karlovy
- 4 Oddělení klinické hematologie, Fakultní nemocnice v Motole, Praha, Česká republika
Subacute stent thrombosis following percutaneous coronary intervention is a rare complication, yet often with a fatal course. The most common causes of this complication include unrecognized coronary artery dissection, final diameter of the implanted stent and its length, and the increasingly more often discussed individual response to dual antiplatelet treatment. Our report presents a case of recurrent stent thrombosis in coincidence with high residual platelet activity despite dual antiplatelet therapy. The condition was successfully treated with switching the patient from clopidogrel to ticlopidine therapy.
Keywords: Subacute thrombosis; Stent; Platelet activity
Published: November 1, 2009 Show citation
References
- Sigwart U, Urban P, Golf S, et al. Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation 1988;78:1121-7.
Go to original source... - Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331: 489-95. Go to original source...
Go to PubMed... - Fischman DL, Leon MB, Baim DS, et al. Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331:496-501. Go to original source... Go to PubMed...
- Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS). Circulation 2000;102:624-9. Go to original source...
- Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005;45:947-53. Go to original source... Go to PubMed...
- Park SJ, Lee SW. Optimal management of platelet function after coronary stenting. Curr Treat Options Cardiovasc Med 2007;9:37-45. Go to original source...
- Bonello L, Camoin-Jau L, Arques S, et al. Adjusted clopidogrel loading doses according to Vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance. J Am Coll Cardiol 2008;14:1404-11. Go to original source... Go to PubMed...
- Regar E, Lemos PA, Saia F, et al. Incidence of thrombotic stent occlusion during first three months after sirolimus-eluting stent implantation in 500 consecutive patients. Am J Cardiol 2004;93:1271-5. Go to original source... Go to PubMed...
- Bliden KP, Chiara J, Tantry US, et al. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneus coronary intervention. J Am Coll Cardiol 2007;49:657-66. Go to original source... Go to PubMed...
- Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistance is associated with increased risk of reccurent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004;109:3171-5. Go to original source... Go to PubMed...
- Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-13. Go to original source... Go to PubMed...
- Geisler T, Langer H, Wydymus M, et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J 2006;27:2420-5. Go to original source... Go to PubMed...
- Cuisset T, Frere C, Quilici J, et al. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost 2006;4:542-9. Go to original source... Go to PubMed...
- Gurbel PA, Becker RC, Mann KG, et al. Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol 2007;19:1822-34. Go to original source... Go to PubMed...
- Barragan P, Bouvier JL, Roquebert PO, et al. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation. Catheter Cardiovasc Interv 2003;59:295-302. Go to original source... Go to PubMed...
- Schwarz UR, Geiger J, Walter U, Eigenthaler M. Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets - definition and detection of ticlopidine/clopidogrel effects. Throm Haemost 1999;82: 1145-52. Go to original source... Go to PubMed...
- Cuisset T, Frere C, Quilici J, et al. Benefit of 600 mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST segment elevation acute coronary syndrome undergoing coronary stenting. J Am Coll Cardiol 2006;48:1339-45. Go to original source... Go to PubMed...
- Campo G, Valgimigli M, Gemmati D, et al. Poor responsiveness to clopidogrel: drug-specific or class effect mechanism? J Am Coll Cardiol 2007;12: 1132-7. Go to original source... Go to PubMed...
- Wiviot SD, Braunwald E, McCabe CH, et al. TRITON-TIMI 38 Investigators: prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15. Go to original source... Go to PubMed...